Calreticulin exposure dictates the immunogenicity of cancer cell death
Nature Medicine2006Vol. 13(1), pp. 54–61
Citations Over TimeTop 1% of 2006 papers
Michel Obéid, Antoine Tesnière, François Ghiringhelli, Gian María Fimia, Lionel Apétoh, Jean‐Luc Perfettini, Maria Castedo, Grégoire Mignot, Theocharis Panaretakis, Noëlia Casares, Didier Métivier, Nathanaël Larochette, Peter Van Endert, Fabiola Ciccosanti, Mauro Piacentini, Laurence Zitvogel, Guido Kroemer
Related Papers
- → Immunogenic cell death and DAMPs in cancer therapy(2012)3,008 cited
- → Leveraging the Immune System during Chemotherapy: Moving Calreticulin to the Cell Surface Converts Apoptotic Death from “Silent” to Immunogenic(2007)158 cited
- → Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference(2007)78 cited
- → The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells(2016)69 cited
- → Immunogenic Cell Death: An opportunity for Clinical Oncology?(2019)2 cited